483 Jiangsu Alpha Pharmaceutical Group Jan 2019

483 Jiangsu Alpha Pharmaceutical Group Jan 2019

Joel Hustedt FDA$119.00 - Available Now

FDA investigators audited the Jiangsu Alpha Pharmaceutical Group - Suqian, China facility and issued inspectional observations (via FDA 483) on 25 Jan 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Jan 2019
  • Location: Suqian, China
  • FEI: 3011765771
Add To Cart